A Clinical Study on the Efficacy and Safety of Ivarmacitinib in Preventing aGVHD After HLA-matched Transplantation
Clinical trial NCT07381114 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07381114
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-14
- Primary completion
- 2026-12-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.